Suppr超能文献

高淋巴管密度和淋巴管浸润均提示乳腺癌预后不良。

High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer.

作者信息

Zhang Song, Zhang Dong, Gong Mingfu, Wen Li, Liao Cuiwei, Zou Liguang

机构信息

Department of Radiology, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.

出版信息

BMC Cancer. 2017 May 17;17(1):335. doi: 10.1186/s12885-017-3338-x.

Abstract

BACKGROUND

Lymphatic vessel density and lymphovascular invasion are commonly assessed to identify the clinicopathological outcomes in breast cancer. However, the prognostic values of them on patients' survival are still uncertain.

METHODS

Databases of PubMed, Embase, and Web of Science were searched from inception up to 30 June 2016. The hazard ratio with its 95% confidence interval was used to determine the prognostic effects of lymphatic vessel density and lymphovascular invasion on disease-free survival and overall survival in breast cancer.

RESULTS

Nineteen studies, involving 4215 participants, were included in this study. With the combination of the results of lymphatic vessel density, the pooled hazard ratios and 95% confidence intervals were 2.02 (1.69-2.40) for disease-free survival and 2.88 (2.07-4.01) for overall survival, respectively. For lymphovascular invasion study, the pooled hazard ratios and 95% confidence intervals were 1.81 (1.57-2.08) for disease-free survival and 1.64 (1.43-1.87) for overall survival, respectively. In addition, 29.56% (827/2798) of participants presented with lymphovascular invasion in total.

CONCLUSIONS

Our study demonstrates that lymphatic vessel density and lymphovascular invasion can predict poor prognosis in breast cancer. Standardized assessments of lymphatic vessel density and lymphovascular invasion are needed.

摘要

背景

通常通过评估淋巴管密度和淋巴管浸润来确定乳腺癌的临床病理结果。然而,它们对患者生存的预后价值仍不确定。

方法

检索了PubMed、Embase和Web of Science数据库,检索时间从建库至2016年6月30日。采用风险比及其95%置信区间来确定淋巴管密度和淋巴管浸润对乳腺癌无病生存期和总生存期的预后影响。

结果

本研究纳入了19项研究,涉及4215名参与者。结合淋巴管密度的结果,无病生存期的合并风险比及95%置信区间分别为2.02(1.69 - 2.40)和总生存期为2.88(2.07 - 4.01)。对于淋巴管浸润研究,无病生存期的合并风险比及95%置信区间分别为1.81(1.57 - 2.08)和总生存期为1.64(1.43 - 1.87)。此外,总共29.56%(827/2798)的参与者出现淋巴管浸润。

结论

我们的研究表明,淋巴管密度和淋巴管浸润可预测乳腺癌的不良预后。需要对淋巴管密度和淋巴管浸润进行标准化评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f72/5436442/ffd3f8bf51fb/12885_2017_3338_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验